Utilisation and safety of rivaroxaban for acute coronary syndrome (ACS) in secondary care in the UK: Results from the rivaroxaban observational safety evaluation post ACS (ROSE-ACS) study
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要